Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05012735Phase 1Completed
Phase 1, randomised, single-blind trial (2 arms), sponsored by Johnson & Johnson. Primary endpoints: Change from Baseline in General Wound Appearance Score of the Popped Pimple at Day 14, Percentage of Healed Popped Pimples at Day 14 and 2 more. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05012735.